复方甘草酸苷联合中药熏蒸及窄谱紫外线治疗银屑病效果分析被引量：5

The Analysis of Effect of Glycyrrhizin Combined with Fumigation and Narrow-band Nltraviolet on Treating Psoriasis

导出

摘要目的:分析复方甘草酸苷联合中药熏蒸及窄谱紫外线治疗银屑病的临床治疗效果。方法:观察组患者给予复方甘草酸苷联合中药熏蒸及窄谱紫外线治疗,对照组患者给予复方甘草酸苷治疗。观察比较两组患者的治疗效果。结果:观察组患者治疗后PASI评分为(4.0±2.1)分明显低于对照组的(7.6±2.4)分,两组比较差异具有统计学意义(P<0.05);观察组的复发率为17.7%明显低于对照组的45.2%,两组比较差异具有统计学意义(P<0.05);观察组的总有效率为88.71%,明显高于对照组的74.19%,两组比较具有显著性差异(P<0.05)。结论:复方甘草酸苷联合中药熏蒸及窄谱紫外线用于治疗银屑病,临床效果显著,值得在临床上推广应用。 Objective： To analyze the clinical effect of Glycyrrhizin combined with Fumigation and Narrow-band ultraviolet on treating Psoriasis. Methods： The patients of the observation group were given the treatment of Glycyrrhizin combined with Fumigation and Narrow-band ultraviolet. The patients of the control group were given the treatment of Glycyrrhizin only. Results： The PASI score of the observation group was （4.0± 2.1） and it was obviously lower than that of the control group （P〈0.05）. The recurrence rate of the observation group was 17.7% and it was obvious lower than that of the control group （P〈0.05）. The total efficiency of the observation group was 87.10% and it was obvious higher than that of the control group （P〈0.05）. Conclusion： The Glycyrrhizin combined with Fumigation and Narrow-band ultraviolet on treating Psoriasis had a significant effect and deserved promotion.

作者杨帆刘孝兵李峰张雪宋印娥

机构地区陕西省安康市中心医院皮肤科

出处《现代生物医学进展》 CAS 2014年第9期1744-1746,共3页 Progress in Modern Biomedicine

关键词复方甘草酸苷中药熏蒸窄谱紫外线银屑病 Glycyrrhizin Fumigation Narrow-band ultraviolet Psoriasis

分类号 R756 [医药卫生—皮肤病学与性病学]

引文网络
相关文献

参考文献20

1Wollina U, Koch A, Scheibe A, et al.Targeted 307 nm UVB-pho- totherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol[J]. Skin Res Technol, 2012,18(2):212-218.
2邱勇龙,黄志明,张磊,张荣,梁瑞.银屑灵联合阿维A治疗寻常型银屑病的疗效研究[J].现代生物医学进展,2009,9(19):3726-3728. 被引量：2
3Garber K. Anti-IL-17 mAbs herald new options in psoriasis [J]. Nat Biotechnol, 2012,30(6):475-477.
4EI-Saie LT, Rabie AR, Kamel MI, et al. Effect of narrowband ultravio- let B phototherapy on serum folic acid levels in patients with psoriasis [J]. Lasers Med Sci, 2011,26(4):481-485.
5Garber K.Psoriasis: from bed to bench and back [J]. Nat Biotechnol, 2011,29(7):563-566.
6Bremmer S, Van Voorhees AS, Hsu S. Obesity and psoriasis:from the Medical Board of the National Psoriasis Foundation [J].J Am Acad Dermatol, 2010,63(6): 1058-1069.
7李鑫,范洁琳.Th17/Treg细胞在银屑病的发病机制研究进展[J].现代生物医学进展,2012,12(24):4769-4772. 被引量：11
8Emerit I, Antunes J, Silva JM, et al. Clastogenic plasma factors in pso- riasis--comparison of phototherapy and anti-TNF-o treatments [J]. Photochem Photobiol, 2011,87(6): 1427-1432.
9Sun LD, Cherig H, Wang ZX. Association analyses identify six new psoriasis susceptibility loci in the Chinese population [J]. Nat Genet, 2010,42(11):1005-1009.
10Jung K, Lee D, Lim HS, et al. Double Anti-angiogenic and Anti-in- flammatory Protein Valpha Targeting VEGF-A and TNF- {alpha} in Retinopathy and Psoriasis[J]. J Biol Chem, 2011,286(16):14410-14418.

二级参考文献62

1Piskin G, Tursen U, Sylva-Steenland RM. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers 1L-12, IL- 18 and IL-23 [J]. Exp Dermatol, 2004, 13(12): 764-772
2Dawe RS, Cameron H, Yule S, et al. A randomized con [1] Piskin G, Tursen U, Sylva-Steenland RM. Clinical improve ment in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers IL-12, IL-18 and IL-23 [J]. Exp Dermatol, 2004, 13(12): 764-772
3Dawe RS, Cameron H, Yule S, et al. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis [J]. Br J Dermatol, 2003, 148 (6): 1194-1204
4Feng Ke, Zhang Mei-hua, Bi Zhi-gang. Effect of NB-UVB on the serum factor in patient with psoriasis vulgaris [J]. J Clin Dermatol, 2004, 33(12): 735-737
5Yang Duo. The progress of immunotherapy on psoriasis vulgaris [J]. Tianjin Pharm, 2007, 19(3), 72-74
6Pasic A, Ceovie R, Lipozencic J, et al. Phototherapy in pediatric patients [J]. Pediatr Dermatol, 2003, 20(1): 71-77
7Feldman SR, Garton R, Averett W. Strategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and cost [J]. Expert Opin Pharmacother, 2003, 4(9): 1525-1533
8Li XH, Fan X, Zhang KM, et al. Influence of psoriatic peripheral blood CD4+T and CD8+ T lymphocytes on C-myc Bcl-XI and Ki67 gene expression in keratinocytes [J]. Eur Dermatol, 2007, 17(5): 392-396
9Mussi A, Boni-ti C, Carducci M. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaquetype psoriasis [J]. J Biol Requl Homeost Agents, 1997, 11: 115-118
10Bemeburg M, Rocken M, Benedix F. Phototherapy with narrowband 5 broadband UVB [J]. Acta Deml Venereol, 2005, 85:98-108